Relevant conflicts of interest/financial disclosures: Both Robert Iansek and Mary Danoudis are authors of a prior article cited in this letter (reference 3). This study by Robert Iansek and Mary Danoudis was funded by Novartis Pharmaceuticals. Novartis Pharmaceuticals was not involved in designing the study, data collection, analysis or interpretation or in writing the report or in the decision to submit the article. Novartis Pharmaceuticals was not involved in the planning, writing, or decision to submit this letter for publication.
Letters: Published Article
Oral formulations of L dopa and continuous dopaminergic stimulation†
Article first published online: 16 FEB 2012
Copyright © 2012 Movement Disorder Society
Volume 27, Issue 4, page 579, April 2012
How to Cite
Iansek, R. and Danoudis, M. (2012), Oral formulations of L dopa and continuous dopaminergic stimulation. Mov. Disord., 27: 579. doi: 10.1002/mds.24953
Full financial disclosures and author roles may be found in the online version of this article.
- Issue published online: 4 APR 2012
- Article first published online: 16 FEB 2012
- Manuscript Accepted: 27 JAN 2012
- Manuscript Revised: 6 JAN 2012
- Manuscript Received: 7 DEC 2011